查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1863097

靜脈輸液裝置市場按產品類型、最終用戶、應用、一次性與可重複使用、便攜性和材質類型分類－2025-2032年全球預測

Intravenous Equipment Market by Product Type, End User, Application, Disposable Vs Reusable, Portability, Material Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，靜脈輸液設備市場規模將達到 215.9 億美元，複合年成長率為 6.29%。

關鍵市場統計數據
基準年 2024 132.4億美元
預計年份：2025年 140.7億美元
預測年份 2032 215.9億美元
複合年成長率 (%) 6.29%

全面了解臨床需求、供應鏈現況和技術趨勢如何重塑各種醫療保健環境中的靜脈輸液治療。

靜脈輸液設備產業處於臨床需求與技術可行性的交匯點，受到不斷變化的醫療環境、日益嚴格的感染控制要求以及對以患者為中心的治療模式日益成長的需求的影響。臨床醫生依賴各種醫療設備和耗材來安全有效地輸注液體、藥物和營養物質，而耐用型輸液幫浦和一次性配件的協同作用仍然是日常診療的核心。隨著住院時間的縮短以及門診和居家醫療的普及，如何平衡便攜性、準確性和成本效益已成為醫療服務提供者和製造商的共同策略重點。

除了不斷變化的臨床環境，供應鏈韌性和日益嚴格的監管也已成為採購的首要考量。醫療系統和採購負責人越來越重視生命週期成本、服務連續性和材料合規性，而不僅僅是單位成本。同時，輸液幫浦智慧化、互聯互通和材料科學領域的創新正在重塑產品藍圖和商業性對話。本導言為報告對臨床趨勢、採購要務和產品演進的探討奠定了基礎，為所有參與靜脈輸液治療的相關人員提供了切實可行的見解。

智慧型設備的普及、護理服務向門診和家庭環境的轉變以及永續性優先事項，正在共同重新定義靜脈輸液治療設備的設計、採購和服務模式。

由於三大因素的共同作用，靜脈輸液設備領域正經歷著變革性的變化：技術進步、照護模式的轉變以及日益成長的監管和永續性要求。整合安全軟體和互通性的智慧型輸液幫浦正從選購功能轉變為高階臨床環境中的必備功能，這迫使原始設備製造商 (OEM) 和醫院 IT 部門投資於設備管理平台和雙向資料流。同時，居家輸液和門診護理的興起推動了對攜帶式、易用型設備以及專為非臨床環境設計的耗材的需求，這使得培訓、遠端監控和供應物流的重要性日益凸顯。

材料創新和環境因素也在推動改變。醫療器材設計人員和採購團隊越來越重視傳統材料的替代品，以解決塑化劑和廢棄物管理方面的問題。同時，製造商正在調整其生產基地和供應商網路，以應對貿易政策的變化和應對危機的計劃。這些變化並非孤立發生；臨床偏好、採購政策和監管指南形成反饋迴路，加速了某些規格和材料的採用，從而影響原始設備製造商 (OEM) 的研發重點和售後服務模式。

評估近期關稅政策對靜脈注射醫療設備生態系統的籌資策略、供應商韌性、採購行為和產品生命週期經濟學的持久影響

近期政策週期中實施的貿易措施正對靜脈輸液器材的供應鏈策略、成本模型和採購決策產生累積影響。關稅帶來的成本壓力迫使製造商和經銷商重新評估其全球採購組合，許多企業加快了生產回流，並選擇低關稅地區的二線供應商，以維持利潤率和交貨保障。醫療系統和集團採購組織則透過收緊合約條款、提高庫存可視性要求以及優先選擇能夠證明其冗餘性和短期交貨保證的供應商來應對這些挑戰。

這些趨勢也會影響產品開發規劃。在採購成本不斷上漲的環境下，負責人傾向於優先考慮價格波動可預測的耗材以及擁有維護合約、能夠平滑生命週期成本的耐用設備。此外，關稅會影響材料替代和製造自動化的經濟效益，促使企業投資於能夠降低勞動密集度並減輕關稅負擔的高價值工藝。市場參與企業採取的因應策略包括策略性庫存、重新談判供應合約以及加強臨床技術與採購部門之間的合作，以檢驗臨床等效替代方案。這些調整會隨著時間的推移改變競爭優勢。能夠透明地管理跨境複雜性並提供持續臨床支援的供應商，將在競標過程中以及建立長期夥伴關係時獲得相對優勢。

詳細的細分分析揭示了產品系列、最終用戶環境、臨床應用、一次性用品選項、便攜性要求和材料選擇如何影響採購和設計優先順序。

細分市場層面的趨勢揭示了不同產品系列、最終用戶、應用、一次性使用選項、便攜性偏好和材料選擇等方面的促進因素和決策標準。在產品類型內部，諸如滴注室、延長管、過濾器和輸液器等配件的選擇通常受採購週期驅動，採購週期側重於無菌保證、兼容性和單位經濟性；而無翼套管和有翼套管的選擇則取決於手術操作環境和臨床醫生的偏好。導管的選擇受臨床因素主導，中央靜脈導管、周邊靜脈導管和周邊置入中央靜脈導管分別適用於不同的治療路徑和感染控制方案。輸液幫浦的技術選擇最為多樣化：彈性體幫浦操作簡單且可一次性使用，適用於門診輸液；胰島素幫浦需要對生命至關重要的精準度和符合人體工學的設計；注射式幫浦滿足小劑量、精確給藥的需求；而容積式幫浦則是高度危重情況下控制給藥的核心。

終端用戶環境進一步影響產品的採用和服務模式。門診醫療機構，例如診所和診斷中心，優先考慮吞吐量、易用性和一次性使用性，以最大限度地降低人員流動風險。另一方面，居家醫療提供者則優先考慮便攜性、病患教育和遠端監測功能。醫院，無論是綜合醫院還是專科醫院，都會投資於互通性、警報管理和預防性保養計劃，以保障病人安全和設備運作。麻醉、加護治療、營養治療、腫瘤和疼痛管理等應用領域具有獨特的性能和監管要求，這些要求會影響採購決策和供應商選擇。一次性設備與可重複使用設備的選擇取決於感染控制通訊協定、整體擁有成本分析和環境政策。便攜性的考量造成了兩種選擇：一種是針對行動性最佳化的行動裝置，另一種是旨在整合到臨床工作流程中的固定系統。聚烯、聚氨酯和聚氯乙烯等材料的選擇反映了柔韌性、化學相容性、生物相容性和監管審查之間的權衡。了解這些相互交織的細分因素，可以讓製造商和負責人將產品規格與臨床工作流程和採購重點保持一致，並設計出滿足每個細分市場細微需求的模式。

美洲、歐洲、中東和非洲以及亞太地區的區域市場特徵和戰略重點將影響製造、監管方法和採用模式。

區域趨勢對靜脈輸液器材的製造、監管路徑和應用模式有著深遠的影響。在美洲，大型綜合醫療保健系統和健全的私人保險體系催生了對兼具臨床療效和成本控制的解決方案的需求。該市場青睞那些能夠提供強大服務網路、相容耗材以及與電子健康記錄系統成熟互通性的供應商。在歐洲、中東和非洲，不同的監管環境和不斷變化的報銷機制要求企業制定客製化的打入市場策略。此外，公私混合醫療體系越來越重視以競標為基礎的採購方式，強調全生命週期價值和符合區域安全標準。在亞太地區，醫院基礎設施的快速投資、對居家醫療日益成長的關注以及充滿活力的製造業基礎，使該地區既成為重要的需求中心，也是全球生產網路的重要組成部分。

每個地區都面臨獨特的物流和競爭挑戰。在美洲，對服務績效記錄和全面維護協議的重視，給尋求長期合約的供應商設置了很高的門檻。在歐洲、中東和非洲，企業需要具備複雜的監管能力，以及服務各種臨床環境的能力，從高度緊急的都市區到資源有限的醫療機構。在亞太地區，技術快速普及和在零件製造中的作用，為策略合作、共同開發和成本競爭性採購創造了機遇，同時也需要考慮當地的合規制度和臨床合作規範。認知到這些區域差異，企業才能優先考慮投資，並客製化價值提案，以滿足不同市場中臨床醫生、採購團隊和監管機構的期望。

競爭格局概述：設備智慧、生命週期服務和供應鏈敏捷性的創新將決定哪些公司能夠獲得長期的商業性和臨床優勢。

靜脈輸液設備領域的競爭動態取決於產品創新、服務能力和供應可靠性的差異化。主要企業正日益將卓越的硬體效能與支援安全性、數據分析和遠端設備管理的軟體功能相結合。售後服務和耗材仍然是維繫客戶忠誠度的重要來源，而提供透明的生命週期成本模型、快速響應的技術支援和以臨床醫生為中心的培訓的供應商則能確保長期的採購優勢。策略夥伴關係、與臨床機構的共同開發契約以及對人體工學研究的投資，能夠增強產品與市場的契合度，並在專業領域建立穩固的地位。

同時，競爭壓力正推動營運效率和敏捷供應鏈策略的發展。擁有供應商多元化、生產靈活性和監管適應能力的公司能夠快速回應政策變化和新興的臨床需求。臨床軟體與互聯設備的整合為新的經營模式創造了機遇，例如將收入與設備運作和效能掛鉤的訂閱服務。鑑於這些趨勢，那些能夠平衡智慧型設備研發投入、嚴謹的商業性執行以及完善的售後支援的公司，將更有利於建立長期的客戶關係，並拓展到其他臨床領域。

製造商和供應商應重點關注以下切實可行的策略重點，以增強醫療設備的互通性、供應鏈韌性、永續性以及將商業性獎勵與臨床結果相一致的服務模式。

產業領導者應採取多管齊下的策略，使產品開發、商業模式和營運韌性與不斷變化的臨床和採購需求保持一致。優先投資於互通性標準和以使用者為中心的設計，以確保輸液幫浦及其配件能夠無縫整合到電子健康記錄 (EHR) 和臨床工作流程中，從而減少警報疲勞並提高輸液通訊協定的依從性。同時，應實現採購管道多元化並對本地供應商進行認證，以降低貿易政策波動帶來的風險，並制定支援庫存可見性和快速補貨的合約條款。在商業產品中建立強大的培訓和遠端支援能力，以增強使用者信心，尤其是在臨床監管分散的門診和居家醫療環境中。

經營團隊還應將永續性和材料替代性作為策略性差異化因素進行評估，並在臨床和監管條件允許的情況下考慮逐步淘汰傳統塑膠。同時，應考慮採用新的服務模式，將部分價值提案從獨立銷售轉向按績效付費合約或設備管理服務，以協調供應商和醫療服務提供者之間的獎勵。最後，應加強臨床工程、採購和產品開發團隊之間的跨職能協作，以加速引入經臨床檢驗的替代方案，並確保採購決策既反映安全要求，也反映長期成本趨勢。這些措施將共同增強企業的競爭力，並使企業能夠靈活應對監管和市場變化。

方法透明度：整合了臨床醫生訪談、監管審查、技術規範分析和供應鏈情境測試的三角驗證研究調查方法的描述

本研究採用混合方法，結合定性相關利益者訪談、技術文獻綜述、監管分析和供應鏈圖譜，整合了各方見解並驗證了研究結果。主要資訊來源包括與急診、門診和居家醫療機構的臨床醫生、採購經理、臨床工程師和生產主管進行結構化對話，以了解實際決策標準和營運限制。二級資訊來源包括醫療設備監管指南、同行評審的臨床研究和製造商技術規範，以檢驗性能聲明和安全性考慮因素。

我們的分析方法包括將訪談主題與已記錄的政策和設備規格進行交叉檢驗，並建立基於情境的評估，以壓力測試供應商的適應能力和產品在不同護理路徑中的適用性。此調查方法的限制包括監管解讀的區域差異以及特定臨床領域技術採納速度的差異。為了降低這些因素的影響，我們與獨立的臨床顧問和採購專家進行了迭代檢驗，以確保研究結果對尋求實用見解的決策者俱有相關性和實用性。

從整體觀點來看，需要將醫療設備專業知識、供應可靠性和永續實踐融入長期靜脈輸液裝置策略中。

總之，靜脈輸液設備策略如今已成為一項多維度的挑戰，它不僅關乎設備性能，還包括互聯互通、供應鏈韌性和環境保護。臨床醫生和採購負責人面臨著相互衝突的優先事項：一方面要確保病人安全和輸液準確性，另一方面要控制總成本並維持業務連續性。能夠平衡產品創新、務實的服務交付和透明的供應策略，以滿足不斷變化的醫療模式的需求，同時又不損害安全性和可及性的企業，將是市場上最成功的參與企業。

決策者應將目前的市場動態視為重塑價值鏈各環節關係的契機，優先選擇那些既展現出臨床同理心又具備營運可靠性的合作夥伴。透過將採購標準與長期設備管理政策相銜接，並採用以服務為導向的商業模式，相關人員可以減少設備推廣應用過程中的阻力，並為持續改善輸液安全性和病患體驗鋪平道路。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 為防止化療藥物污染，越來越多採用封閉式輸送系統。
  • 智慧型輸液幫浦正與醫院資訊系統整合，以提高用藥安全性。
  • 無針連接器的研發降低了導管相關血流感染的發生率。
  • 主要製造商越來越重視靜脈注射靜脈輸液包裝材料的永續性
  • 無線遠端監測靜脈輸液技術的進步有助於改善患者預後
  • 為最大限度減少加護治療環境中的輸液錯誤，對整合藥物庫軟體的需求激增
  • 在院外環境中，穿戴式輸液幫浦在持續皮下治療的應用日益廣泛
  • 擴大一次性生物處理袋的使用範圍，以簡化靜脈注射藥物生產的生產流程。
  • 肝素塗層導管的創新可通暢性
  • 引入方便病患使用的配藥裝置，以提高醫院藥局無菌靜脈輸液配製效率

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的靜脈輸液設備市場

  • 配件
    • 滴液室
    • 延長管
    • 篩選
    • 點滴器
  • 套管
    • 無翅
    • 長著翅膀
  • 導管
    • 中央
    • 外圍
    • 周邊置入中央靜脈導管
  • 點滴幫浦
    • 彈性體泵
    • 胰島素幫浦
    • 注射式幫浦
    • 容積式泵

9. 依最終用戶分類的靜脈輸液設備市場

  • 門診治療
    • 診所
    • 診斷中心
  • 居家醫療
  • 醫院
    • 一般的
    • 專科診所

第10章 依應用分類的靜脈輸液裝置市場

  • 麻醉
  • 加護治療
  • 營養療法
  • 腫瘤學
  • 疼痛管理

第11章 靜脈輸液裝置市場（依一次性裝置和可重複使用裝置分類）

  • 一次性的
  • 可重複使用的

第12章 依便攜性分類的靜脈輸液設備市場

  • 攜帶式的
  • 固定式

第13章 依材料類型分類的靜脈輸液裝置市場

  • 聚烯
  • 聚氨酯
  • 聚氯乙烯

14. 按地區分類的靜脈輸液設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 靜脈輸液裝置市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各國靜脈輸液設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Becton, Dickinson and Company
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Fresenius Kabi AG
    • Terumo Corporation
    • ICU Medical, Inc.
    • Smiths Medical, Inc.
    • Nipro Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Medtronic plc
Product Code: MRR-F6513A06BEE9

The Intravenous Equipment Market is projected to grow by USD 21.59 billion at a CAGR of 6.29% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 13.24 billion
Estimated Year [2025] USD 14.07 billion
Forecast Year [2032] USD 21.59 billion
CAGR (%) 6.29%

A comprehensive orientation to the clinical imperatives, supply chain realities, and technological trajectories that are reshaping intravenous therapy delivery across care settings

The intravenous equipment arena stands at the intersection of clinical necessity and technological possibility, shaped by changing care settings, heightened infection control expectations, and accelerating demand for patient-centric delivery models. Clinicians rely on a broad array of devices and consumables to deliver fluids, medications, and nutrition safely and effectively, and the interplay between durable infusion pumps and single-use accessories remains central to daily practice. As inpatient stays shorten and outpatient and home-based care expand, the balance between portability, precision, and cost-efficiency has become a strategic priority for providers and manufacturers alike.

Beyond clinical dynamics, supply chain resilience and regulatory rigor have moved to the forefront of buyer criteria. Health systems and procurement leaders increasingly evaluate not only unit price but also lifecycle costs, service continuity, and material compliance. Simultaneously, innovation in pump intelligence, connectivity, and materials science is redefining product roadmaps and commercial conversations. This introduction frames the report's exploration of clinical trends, procurement imperatives, and product evolution, providing a foundation for actionable insights across stakeholders involved in intravenous therapy delivery.

How smart device integration, care delivery migration to outpatient and home settings, and sustainability priorities are jointly redefining intravenous equipment design, procurement, and service models

The landscape for intravenous equipment is undergoing transformative shifts driven by three converging forces: technological advancement, care model migration, and heightened regulatory and sustainability expectations. Smart infusion pumps with integrated safety software and interoperability capabilities are moving from optional enhancements to core requirements in higher acuity settings, prompting OEMs and hospital IT teams to invest in device management platforms and bidirectional data flows. At the same time, the proliferation of home infusion and ambulatory care has elevated demand for portable, user-friendly devices and single-use accessories designed for nonclinical environments, which places new emphasis on training, remote monitoring, and supply logistics.

Material innovation and environmental considerations are also driving change. Device designers and procurement teams are increasingly prioritizing alternatives to legacy materials to address concerns about plasticizers and waste management. Meanwhile, manufacturers are reconfiguring production footprints and supplier networks in response to trade policy shifts and resilience planning. Collectively, these shifts are not isolated; they create feedback loops in which clinical preferences, procurement policies, and regulatory guidance accelerate adoption of particular form factors and materials, thereby influencing OEM development priorities and aftermarket service models.

Assessing the persistent effects of recent tariff policies on sourcing strategies, supplier resilience, procurement behavior, and product lifecycle economics within the intravenous equipment ecosystem

Trade measures implemented in recent policy cycles have exerted a cumulative influence on supply chain strategies, costing models, and sourcing decisions for intravenous equipment. Tariff-driven cost pressures have compelled manufacturers and distributors to re-evaluate global sourcing mixes, with many accelerating reshoring efforts or qualifying secondary suppliers in lower-tariff jurisdictions to preserve margin and delivery reliability. Health systems and group purchasing organizations have responded by tightening contract terms, extending inventory visibility requirements, and placing a premium on suppliers that can demonstrate redundancy and near-term delivery assurances.

These dynamics also shape product roadmaps. When procurement faces elevated input costs, buyers tend to prioritize consumables with predictable pricing and durable equipment with service agreements that smooth lifecycle expenses. In addition, tariffs can influence the economics of material substitution and manufacturing automation, incentivizing investment in higher-value processes that reduce labor intensity or lower tariff exposure. Mitigation strategies adopted by market participants include strategic stockpiling, renegotiation of supply contracts, and enhanced collaboration between clinical engineering and procurement to validate clinically equivalent alternatives. Over time, such adjustments alter competitive positioning: suppliers that can transparently manage cross-border complexity and provide consistent clinical support gain relative advantage in tender processes and long-term partnerships.

In-depth segmentation analysis revealing how product families, end-user settings, clinical applications, disposability choices, portability demands, and material selections determine procurement and design priorities

Segment-level dynamics reveal distinct drivers and decision criteria across product families, end users, applications, disposability choices, portability preferences, and material selection. Within product types, accessories such as drip chambers, extension tubing, filters, and infusion sets are often governed by procurement cycles that prize sterility assurance, compatibility, and unit economics, whereas cannula choices between non-winged and winged variants hinge on procedural context and clinician preference. Catheter selection is clinically driven, with central, peripheral, and peripherally inserted central catheters each serving different care pathways and infection control regimes. Infusion pumps present the broadest range of technical trade-offs: elastomeric pumps offer simplicity and disposability for ambulatory infusion, insulin pumps demand life-critical accuracy and user ergonomics, syringe pumps address small-volume precision needs, and volumetric pumps are central to controlled delivery in higher acuity settings.

End-user context further shapes product adoption and service models. Ambulatory care settings such as clinics and diagnostic centers focus on throughput, ease of use, and disposability to minimize turnover risk, while home healthcare providers prioritize portability, patient education, and remote monitoring capabilities. Hospitals, whether general or specialty, invest in interoperability, alarm management, and preventive maintenance programs to protect patient safety and asset uptime. Application areas like anesthesia, critical care, nutrition therapy, oncology, and pain management impose distinct performance and regulatory expectations that influence purchasing decisions and vendor selection. The disposable versus reusable calculus is informed by infection control protocols, total cost of ownership analyses, and environmental policy. Portability considerations create a bifurcation between portable devices optimized for mobility and stationary systems designed for integration into clinical workflows. Material selection among polyolefin, polyurethane, and polyvinyl chloride reflects trade-offs between flexibility, chemical compatibility, biocompatibility, and regulatory scrutiny. Understanding these intersecting segmentation vectors enables manufacturers and purchasers to align product specifications with clinical workflows and procurement priorities, and to design service models that respond to the nuanced needs of each segment.

Regional market signatures and strategic priorities across the Americas, Europe Middle East and Africa, and Asia-Pacific that influence manufacturing, regulatory approach, and adoption patterns

Regional dynamics have profound implications for manufacturing, regulatory pathways, and adoption patterns across the intravenous equipment landscape. In the Americas, large integrated health systems and a robust private payer environment create demand for solutions that combine clinical performance with cost containment; this market favors suppliers that offer strong service networks, compatible consumables, and demonstrated interoperability with electronic health records. Across Europe, the Middle East, and Africa, regulatory diversity and variable reimbursement landscapes require tailored market entry strategies, and hybrid public-private systems often prioritize tender-based procurement that emphasizes total lifecycle value and compliance with regional safety standards. In the Asia-Pacific region, rapid investment in hospital infrastructure, a growing emphasis on home healthcare, and a dynamic manufacturing base position the region as both a major demand center and a critical node in global production networks.

Each region also presents distinct logistical and competitive challenges. The Americas' emphasis on documented service performance and bundled maintenance agreements raises the bar for suppliers seeking long-term contracts. Europe, the Middle East, and Africa demand nuanced regulatory navigation and an ability to serve heterogeneous clinical contexts, from high-acuity urban centers to resource-constrained facilities. Asia-Pacific's pace of technological adoption and its role in component manufacturing create opportunities for strategic partnerships, joint development, and cost-competitive sourcing, while also requiring attention to local compliance regimes and language of clinical engagement. Recognizing these regional signatures enables companies to prioritize investments and tailor value propositions to meet the expectations of clinicians, procurement teams, and regulators across diverse markets.

Competitive landscape overview where innovation in device intelligence, lifecycle services, and supply chain agility determines who captures long-term commercial and clinical advantage

Competitive dynamics within the intravenous equipment space are defined by differentiation along product innovation, service capability, and supply reliability. Leading companies increasingly combine hardware excellence with software-enabled features that support safety, analytics, and remote device management. Aftermarket services and consumables remain a durable source of customer lock-in, and providers that offer transparent lifecycle cost models, rapid technical support, and clinician-focused training secure long-term procurement advantages. Strategic partnerships, co-development arrangements with clinical institutions, and investments in human factors research bolster product-market fit and create defensible positions in specialty segments.

At the same time, competitive pressure incentivizes operational efficiency and nimble supply chain strategies. Companies that excel in supplier diversification, manufacturing flexibility, and regulatory agility can respond more rapidly to policy changes and emergent clinical needs. The convergence of clinical software and connected devices opens opportunities for new commercial models, including subscription-based service offerings that align revenue with device uptime and performance. Given these dynamics, firms that balance R&D investment in smart device capabilities with disciplined commercial execution and robust post-sale support will be best positioned to capture durable customer relationships and to expand into adjacent care settings.

Practical strategic priorities for manufacturers and providers to enhance device interoperability, supply resilience, sustainability, and service models that align commercial incentives with clinical outcomes

Industry leaders should adopt a multi-pronged strategy that aligns product development, commercial models, and operational resilience with evolving clinical and procurement expectations. Prioritize investments in interoperability standards and user-centered design to ensure that pumps and accessories integrate seamlessly into electronic health records and clinical workflows, thereby reducing alarm fatigue and improving adherence to infusion protocols. Simultaneously, diversify sourcing and qualify regional suppliers to reduce exposure to trade policy volatility, while developing contractual terms that support inventory visibility and rapid replenishment. Embedding robust training and remote support capabilities into commercial offerings will enhance user confidence, particularly in ambulatory and home-care contexts where clinical oversight is distributed.

Leaders should also evaluate sustainability and material substitution as strategic differentiators, exploring transitions away from legacy plastics where clinically and regulatorily feasible. Consider novel service models that shift part of the value proposition from unit sales to outcome-based contracts or managed device services, aligning incentives across providers and suppliers. Finally, cultivate cross-functional engagement between clinical engineering, procurement, and product teams to accelerate adoption of clinically validated alternatives and to ensure procurement decisions reflect both safety imperatives and long-term cost dynamics. These measures collectively strengthen competitive position and enable organizations to respond nimbly to regulatory and market shifts.

Methodological transparency describing a triangulated research approach that integrates clinician interviews, regulatory review, technical specification analysis, and supply chain scenario testing

This research synthesizes insights from a mixed-methods approach combining qualitative stakeholder interviews, technical literature review, regulatory analysis, and supply chain mapping to triangulate findings. Primary inputs included structured conversations with clinicians across acute, ambulatory, and home settings, procurement leaders, clinical engineers, and manufacturing executives to capture real-world decision criteria and operational constraints. Secondary sources encompassed device guidance from regulatory authorities, peer-reviewed clinical studies, and manufacturer technical specifications to validate performance claims and safety considerations.

Analytical methods involved cross-validating interview themes with documented policies and device specifications, and constructing scenario-based assessments to stress-test supplier resilience and product fit across diverse care pathways. Limitations of the methodology include potential variability in regional regulatory interpretation and the pace of technological adoption in specific clinical niches. To mitigate these factors, findings were subjected to iterative validation with independent clinical advisors and procurement specialists to ensure relevance and practical applicability for decision-makers seeking actionable intelligence.

Summative perspective emphasizing the need to integrate device intelligence, supply reliability, and sustainable practices into long-term intravenous equipment strategies

In conclusion, intravenous equipment strategy is now a multidimensional challenge that extends beyond device performance to encompass connectivity, supply chain resilience, and environmental stewardship. Clinicians and procurement leaders face competing priorities: ensuring patient safety and precision of delivery while managing total cost and operational continuity. The most successful market participants will be those that harmonize product innovation with practical service offerings and transparent supply strategies, enabling providers to meet the demands of shifting care models without compromising safety or accessibility.

Decision-makers should view current market dynamics as an opportunity to rearchitect relationships across the value chain, privileging partners who demonstrate both clinical empathy and operational reliability. By aligning procurement criteria with long-term device stewardship and by adopting service-oriented commercial models, stakeholders can reduce friction in device adoption and create pathways for sustained improvement in infusion safety and patient experience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of closed system transfer devices to prevent chemotherapy drug contamination
  • 5.2. Integration of smart infusion pumps with hospital information systems to enhance medication safety
  • 5.3. Development of needle-free connectors to reduce catheter-related bloodstream infections
  • 5.4. Increased focus on sustainability in IV disposable packaging materials by major manufacturers
  • 5.5. Advancement in wireless remote monitoring of intravenous fluid delivery to improve patient outcomes
  • 5.6. Surge in demand for integrated drug library software to minimize infusion errors in critical care settings
  • 5.7. Growing implementation of on-body infusion pumps for continuous subcutaneous therapies outside hospital settings
  • 5.8. Expansion of single-use bioprocessing bags for intravenous drug manufacturing to streamline production workflows
  • 5.9. Innovations in heparin-coated catheters for prolonged patency in long-term infusion therapies
  • 5.10. Adoption of near-patient compounding units to improve sterile IV preparation efficiency in hospital pharmacies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravenous Equipment Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Drip Chambers
    • 8.1.2. Extension Tubing
    • 8.1.3. Filters
    • 8.1.4. Infusion Sets
  • 8.2. Cannula
    • 8.2.1. Non Winged
    • 8.2.2. Winged
  • 8.3. Catheters
    • 8.3.1. Central
    • 8.3.2. Peripheral
    • 8.3.3. Peripherally Inserted Central
  • 8.4. Infusion Pumps
    • 8.4.1. Elastomeric Pumps
    • 8.4.2. Insulin Pumps
    • 8.4.3. Syringe Pumps
    • 8.4.4. Volumetric Pumps

9. Intravenous Equipment Market, by End User

  • 9.1. Ambulatory Care
    • 9.1.1. Clinics
    • 9.1.2. Diagnostic Centers
  • 9.2. Home Healthcare
  • 9.3. Hospital
    • 9.3.1. General
    • 9.3.2. Specialty Clinics

10. Intravenous Equipment Market, by Application

  • 10.1. Anesthesia
  • 10.2. Critical Care
  • 10.3. Nutrition Therapy
  • 10.4. Oncology
  • 10.5. Pain Management

11. Intravenous Equipment Market, by Disposable Vs Reusable

  • 11.1. Disposable
  • 11.2. Reusable

12. Intravenous Equipment Market, by Portability

  • 12.1. Portable
  • 12.2. Stationary

13. Intravenous Equipment Market, by Material Type

  • 13.1. Polyolefin
  • 13.2. Polyurethane
  • 13.3. Polyvinyl Chloride

14. Intravenous Equipment Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Intravenous Equipment Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Intravenous Equipment Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Becton, Dickinson and Company
    • 17.3.2. Baxter International Inc.
    • 17.3.3. B. Braun Melsungen AG
    • 17.3.4. Fresenius Kabi AG
    • 17.3.5. Terumo Corporation
    • 17.3.6. ICU Medical, Inc.
    • 17.3.7. Smiths Medical, Inc.
    • 17.3.8. Nipro Corporation
    • 17.3.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 17.3.10. Medtronic plc

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. INTRAVENOUS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. INTRAVENOUS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAVENOUS EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 304. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 316. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 320. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY DISPOSABLE VS REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 322. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY